SPX -0.95% VIX -2.46%
STOCKS SET TO SNAP BACK AS MNUCHIN SAYS U.S. WAS 90% OF THE WAY THERE ON CHINA 
ROBERT MUELLER AGREES TO TESTIFY BEFORE HOUSE COMMITTEES ON JULY 17 
MICRON STOCK RISES 4% AS EARNINGS BEAT LOWERED BAR 
NASDAQ DROPS 1.5%, LEADING BENCHMARKS LOWER, AS FED DAMPENS RATE-CUT ENTHUSIASM 
STOCK MARKET HITS INTRADAY LOWS AS FED'S BULLARD DOWNPLAYS 'HUGE ACTION' IN JULY 
CONSUMER CONFIDENCE FALLS TO LOWEST LEVEL IN 21 MONTHS; NEW-HOME SALES FALTER 
STOCKS OPEN STEADY; POWELL'S SPEECH IN FOCUS 
ANNUAL HOME-PRICE GAINS SLOW FOR 13TH STRAIGHT MONTH: CASE-SHILLER 
10-YEAR TREASURY YIELD DIPS BELOW 2% 
NEED TO KNOW: FORGET THE PREDICTIONS FOR RECESSION, WE'RE ALREADY THERE 
Wed, Jun 26 8:02am


argenx SE - American Depositary Shares [ARGX]
$139.26 0.43 (0.31%)

ARGX Profile

Sector Health Care
Industry Biotech & Pharma
Market Cap 5.32 Billion
ARGX Description

argenx SE is a clinical stage biotechnology company. It is engaged in the business of developing a pipeline of differentiated antibody-based therapies for the treatment of severe autoimmune diseases and cancer. Its product pipeline includes product candidates such as ARGX-113, ARGX-110, ARGX-115, ARGX-112 etc. The company operates in the Netherlands, Germany, Denmark, Belgium, Switzerland, the United States, and Luxembourg. It derives the majority of its revenues from Luxembourg.


Visit Website

ARGX Earnings

EPS -0.08 P/E Ratio 0.00
Previous Earnings --
Latest Earnings Thu, Oct 25, 2018 (244 days ago) +78.88%

ARGX Dividend

Yield --
Ex-Date --
Pay Date --
History --

ARGX Charts

$63.81
52 Week Range
$140.15
Oct 10, 2018
Jun 21, 2019



Symbol Price Day % YTD %
ARGX $139.26 -0.31% 40.88%

Symbol Surfing

How can we make Symbol Surfing better?

info@symbolsurfing.com

Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.



©2019 Symbol Surfing All Rights Reserved.

Cookies Policy | Terms Of Service | Privacy Policy